Roche Launches Compact Analyzer for Small-to-Medium-Sized Labs
Cobas pure integrated solutions is a new compact analyzer that combines three technologies in a single platform to simplify daily operations at labs with limited space and resources.
Roche announced the launch of cobas pure integrated solutions, a new compact analyzer that combines three technologies in a single platform to simplify daily operations at labs with limited space and resources.
With a footprint of 2 m2, the analyzer focuses on the automation of manual tasks by performing up to 870 tests per hour while providing a full clinical chemistry and immunochemistry assay menu, which includes more than 230 diagnostic tests, Roche said in a March 17, 2021 press release. Additionally, the analyzer provides fully standardized results and operation to Roche’s cobas pro, its analyzer for large labs, and is compatible with the cobas mobile solution, a tablet that allows users to interact with the analyzer from anywhere in the lab.
“During these challenging times, providing accurate and timely testing has never been more vital. Roche continues to invest heavily in laboratory innovation to help meet the changing demands of healthcare systems,” said Thomas Schinecker, CEO Roche Diagnostics, in the press release. “With the launch of cobas pure integrated solutions, we seek to simplify complex workflows in small-to-medium-sized labs so that laboratory professionals can focus on providing clinicians with the information they need to make reliable and timely clinical decisions for patients.”
Source: Roche
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
